1. Home
  2. TOWN vs BEAM Comparison

TOWN vs BEAM Comparison

Compare TOWN & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TowneBank

TOWN

TowneBank

HOLD

Current Price

$36.63

Market Cap

3.2B

Sector

Finance

ML Signal

HOLD

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

HOLD

Current Price

$25.19

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TOWN
BEAM
Founded
1998
2017
Country
United States
United States
Employees
1939
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.0B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
TOWN
BEAM
Price
$36.63
$25.19
Analyst Decision
Buy
Analyst Count
0
12
Target Price
N/A
$50.75
AVG Volume (30 Days)
724.9K
2.6M
Earning Date
04-22-2026
05-06-2026
Dividend Yield
3.09%
N/A
EPS Growth
N/A
82.31
EPS
N/A
N/A
Revenue
N/A
$24,000.00
Revenue This Year
$35.63
N/A
Revenue Next Year
$5.18
$33.77
P/E Ratio
$16.23
N/A
Revenue Growth
N/A
33.33
52 Week Low
$31.91
$15.60
52 Week High
$37.86
$38.26

Technical Indicators

Market Signals
Indicator
TOWN
BEAM
Relative Strength Index (RSI) 58.29 30.23
Support Level $35.12 $24.80
Resistance Level $37.44 $33.32
Average True Range (ATR) 0.70 1.99
MACD -0.03 -0.94
Stochastic Oscillator 72.88 1.83

Price Performance

Historical Comparison
TOWN
BEAM

About TOWN TowneBank

Towne Bank is a financial services company serving individuals, commercial enterprises and professionals, offering retail and commercial banking services in Virginia and North Carolina. The company has four reportable segments: Banking, which provides loan and deposit services, commercial mortgage brokerage, and investment and asset management services; Mortgage, which originates mortgage loans principally sold in the secondary market through purchase commitments from investors; Resort Vacation Management, which provides residential resort property management services; and Insurance, which provides property, casualty, life and health insurance solutions for businesses, individuals and community organizations through a variety of carriers.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company operates and manages its business in one operating segment, United States.

Share on Social Networks: